Sonoelastography makes hardened cancer tissue visible

Sonoelastography, a procedure that measures the elasticity of tissue and differentiates between healthy and hardened pathological tissue, will make cancer diagnosis safer in the future. For example, it has been shown to improve the accuracy of prostate cancer diagnosis by 20%.

Aspects of the application of this procedure were discussed at the 32nd Three Nations Meeting of the German, Austrian and Swiss Societies for Ultrasound in Medicine (DEGUM, ÖGUM, SGUM) this September in Davos.
From soft, fatty tissue to the bone-hard skeleton: The elasticity of the tissue in the human body varies from 0.5 to 1,000 kPA (kilopascal). To assess tissue hardness, the physician first palpates palpate the tissue by hand.

‘However, from a diagnostic perspective it is far more precise and safer to examine these structures with a sonoelastograph,’ explained Professor Christoph Dietrich MD, internist at the Caritas Hospital in Bad Mergentheim, and DEGUM representative (Honorary Secretary) of the respective European association (European Federation of Societies for Ultrasound in Medicine and Biology; EFSUMB). Pressure waves from the rhythmically vibrating ultrasound transducer reach areas not accessible to hands – the less elastic the tissue, all the quicker. Apart from the prostate, this type of tissue includes the lymph nodes between the lung lobes (mediastinum), the pancreas and organs of the digestive and reproductive tracts.
In a suspected prostate cancer case, doctors remove tissue samples using a hollow needle, which carries the risk of bleeding and infection of the prostate. A negative sample result could mean the doctor has not punctured the precise tumour location, Prof. Dietrich explained. ‘Previously, the exact location of small tumours was not sufficiently detectable. This is why the prostate should be elastographically examined before a biopsy,’ to locate tumours, avoid incorrect diagnoses and make biopsies more accurate. Sonoelastography, he emphasised, makes it possible to cut out suspicious tissue with 20% higher accuracy.
The procedure also improves the hit rate of biopsies for other diseases. Cancerous milk ducts in the breast, or fatty tissue in the liver can be reliably told apart from healthy tissue. ‘The spectrum is broad – not least because the development of sonoelastography was always based around its application in practice,’ he added.
In addition, for internal ultrasound examinations, e.g. bowel or vagina, sonoelastography can be combined with special probes.

19.11.2008

More on the subject:

Related articles

Photo

Article • Support for clinicians beyond initial diagnosis

Enhancing breast imaging with AI

Artificial intelligence has a critical role to play in supporting clinicians beyond the initial breast cancer diagnosis. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting…

Photo

News • Imaging solutions

Fujifilm to unveil new ultrasound platforms at ECR 2026

Fujifilm Healthcare Europe will present the new Arietta DeepInsight x ultrasound technology platforms at the House of Fujifilm experience at ECR 2026: Rays of Knowledge.

Photo

News • Ultrasound, MRI and Enterprise Imaging

Esaote presents new imaging solutions at ECR 2026

Italian imaging company Esaote will be at the European Congress of Radiology 2026 (Booth 505, Expo Hall X5) and present latest additions to their ultrasound, MRI and Enterprise Imaging portfolio.

Subscribe to Newsletter